IWC
PRAX icon

Integrated Wealth Concepts’s Praxis Precision Medicines PRAX Stock Holding History

Integrated Wealth Concepts’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2K Buy
+114
New +$36.1K ﹤0.01% 3578

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Integrated Wealth Concepts's PRAX Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 114 shares worth $38.2K. The stake represents ﹤0.01% of the portfolio and ranks #3578 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Integrated Wealth Concepts held 114 shares of Praxis Precision Medicines worth $38.2K as of Q2 2026.
  • Praxis Precision Medicines was a new Integrated Wealth Concepts position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3578 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.